ReviewZeitschrift fur Gerontologie und Geriatrie2007
[Prevention of adverse drug reactions in older patients].
Review in Zeitschrift fur Gerontologie und Geriatrie, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Article
- Medication Lists and Brown Bag Reviews: Potential Positive and Negative Impacts on Patients Beliefs about Their Medicine.BioMed research international · 2015Article
- [Pain management in elderly patients].Zeitschrift fur Rheumatologie · 2014Article
- General practitioners' views on polypharmacy and its consequences for patient health care.BMC family practice · 2013Article
- [Depression in frail geriatric patients. Diagnostics and treatment].Zeitschrift fur Gerontologie und Geriatrie · 2013Review
- [Coping with chronic illness and multiple medicines in older age: self-management support as an obligation in nursing].Zeitschrift fur Gerontologie und Geriatrie · 2011Article
- [Options for health care promotion in long-term care: empirical evidence and conceptual approaches].Zeitschrift fur Gerontologie und Geriatrie · 2009Article
- [Delirium in the elderly].Zeitschrift fur Gerontologie und Geriatrie · 2008Review
- [Dementia--a secondary diagnosis in acute hospital care or more? Measures for improving care of hospitalized dementia patients].Zeitschrift fur Gerontologie und Geriatrie · 2008Article
- [Transactional model of suicidal behavior in the elderly].Zeitschrift fur Gerontologie und Geriatrie · 2008Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adverse drug reactions are among the most common adverse events and a significant cause of preventable morbidity and mortality. As multimorbidity and polypharmacy are frequent in this population, the elderly are at special risk for adverse drug events, although the calendar age has not been proved as independent risk factor in this context. In particular falls and delirium are clinically significant and typical adverse drug events in the elderly. In this review mechanisms and factors which determine adverse drug re actions are described, and possible strategies for an effective prevention are given. This covers pharmacokinetic, pharmacogenetic and pharmacodynamic aspects as well as factors influencing individual adherence to drug therapy. A significant portion of adverse drug reaction may be prevented by a thorough indication and prudent monitoring of pharmacotherapy. Also adherence to pharmacotherapy may be improved by tailored and individual means referring to the patient's needs and expectancies. In the elderly functional limitations such as reduced cognitive abilities, reduced visual acuity and impaired dexterity determine an ineffective pharmacotherapy and medication errors. Hereby these functional limitations are significant predictors of adverse drug events in the context of self-management of pharmacotherapy. Testing of functional abilities as provided in the geriatric assessment is helpful to identify these factors. Among altered pharmacokinetic factors in the elderly, reduced renal function is most important to avoid overdosage. Although a precise measurement of renal function is not possible in a bed-side manner, an estimation of actual renal function utilizing estimation-formulas should always take place.
Indexed as
Identifiers
17701115What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.